Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Information Circular posted

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Apr 16, 2021 8:47pm

90 Views

Post# 33016004

RE:RE:Information Circular posted

You think it's negative or mr market thinks it's negative?

SPCEO1 wrote: It looks like Pommier and Frame are retiring. Arena is another Pfizer alum. Looks like we have some weekend reading.

No surprise they did a Friday night drop of this.

1998novl wrote: A new Board Member up for election, Joseph Arena.